Table 3 ORs of childhood tumors in the proximity of industrial and urban areas

≤ 5

Leukemias [8]

1.13 (0.83–1.56)

1.41 (0.76–2.61)

1.05 (0.77–1.44)

Renal [5]

1.85 (1.07–3.18)

1.28 (0.35–4.75)

1.90 (1.00–3.59)

Neuroblastoma [7]

1.30 (0.89–1.91)

1.83 (0.78–4.33)

1.41 (0.90–2.20)

Bone [4]

NA^a

NA^a

NA^a

Retinoblastoma [6]

1.33 (0.73–2.44)

2.08 (0.58–7.42)

0.94 (0.45–1.94)

Hepatic [6]

0.60 (0.24–1.48)

0.31 (0.06–1.75)

0.45 (0.14–1.48)

Soft tissue sarcomas [6]

0.60 (0.39–0.93)

0 (0–inf)

0.81 (0.48–1.37)

Germ cell tumors [6]

1.28 (0.68–2.40)

1.76 (0.33–9.52)

1.31 (0.62–2.76)

Other epithelial neoplasms/melanomas [6]

1.24 (0.29–5.35)

0 (0–inf)

0.58 (0.09–3.63)

Central nervous system [10]

NA^a

NA^a

NA^a

≤ 4

Leukemias [8]

1.26 (0.94–1.70)

1.66 (1.08–2.55)

1.12 (0.83–1.50)

Renal [5]

1.91 (1.11–3.29)

1.65 (0.71–3.81)

1.92 (1.00–3.71)

Neuroblastoma [7]

1.29 (0.88–1.90)

1.46 (0.82–2.60)

1.42 (0.90–2.25)

Bone [4]

NA^a

NA^a

NA^a

Retinoblastoma [6]

1.31 (0.71–2.40)

1.16 (0.46–2.92)

0.96 (0.45–2.04)

Hepatic [6]

0.60 (0.24–1.48)

0.31 (0.06–1.75)

0.45 (0.14–1.48)

Soft tissue sarcomas [6]

0.59 (0.38–0.93)

0.51 (0.23–1.17)

0.81 (0.47–1.39)

Germ cell tumors [6]

1.24 (0.65–2.34)

0.98 (0.32–3.02)

1.43 (0.67–3.08)

Other epithelial neoplasms/melanomas [6]

1.40 (0.32–6.14)

0 (0–inf)

0.73 (0.12–4.62)

Central nervous system [10]

NA^a

NA^a

NA^a

≤ 3

Leukemias [8]

1.26 (0.97–1.63)

1.29 (0.92–1.80)

1.10 (0.85–1.42)

Renal [5]

1.96 (1.13–3.39)

1.12 (0.52–2.43)

2.62 (1.34–5.12)

Neuroblastoma [7]

1.28 (0.87–1.89)

1.38 (0.84–2.27)

1.48 (0.91–2.41)

Bone [4]

2.33 (1.17–4.63)

4.43 (1.80–10.92)

3.66 (1.53–8.75)

Retinoblastoma [6]

1.31 (0.71–2.42)

1.33 (0.60–2.93)

0.76 (0.32–1.76)

Hepatic [6]

0.60 (0.24–1.50)

0.44 (0.12–1.66)

0.36 (0.10–1.42)

Soft tissue sarcomas [6]

0.64 (0.41–1.00)

0.60 (0.31–1.15)

0.86 (0.48–1.54)

Germ cell tumors [6]

1.23 (0.64–2.34)

1.28 (0.55–3.00)

1.38 (0.60–3.18)

Other epithelial neoplasms/melanomas [6]

1.45 (0.33–6.37)

0 (0–inf)

1.08 (0.17–6.93)

Central nervous system [10]

NA^a

NA^a

NA^a

≤ 2.5

Leukemias [8]

1.31 (1.03–1.67)

1.36 (1.02–1.80)

1.07 (0.84–1.36)

Renal [5]

1.97 (1.13–3.42)

1.38 (0.67–2.81)

2.62 (1.30–5.30)

Neuroblastoma [7]

1.33 (0.90–1.97)

1.32 (0.81–2.13)

1.62 (0.98–2.69)

Bone [4]

2.19 (1.10–4.39)

4.08 (1.72–9.64)

3.89 (1.55–9.76)

Retinoblastoma [6]

NA^a

NA^a

NA^a

Hepatic [6]

NA^a

NA^a

NA^a

Soft tissue sarcomas [6]

NA^a

NA^a

NA^a

Germ cell tumors [6]

NA^a

NA^a

NA^a

Other epithelial neoplasms/melanomas [6]

NA^a

NA^a

NA^a

Central nervous system [10]

NA^a

NA^a

NA^a

≤ 2

Leukemias [8]

1.31 (1.04–1.65)

1.28 (1.00–1.53)

1.00 (0.79–1.26)

Renal [5]

2.02 (1.16–3.52)

1.37 (0.69–2.73)

3.14 (1.50–6.58)

Neuroblastoma [7]

1.27 (0.85–1.90)

1.22 (0.76–1.96)

2.12 (1.18–3.83)

Bone [4]

1.97 (0.97–4.02)

4.02 (1.73–9.34)

3.90 (1.48–10.29)

Retinoblastoma [6]

1.38 (0.73–2.59)

1.19 (0.57–2.52)

0.69 (0.26–1.84)

Hepatic [6]

0.65 (0.25–1.68)

0.33 (0.10–1.16)

0.60 (0.13–2.71)

Soft tissue sarcomas [6]

0.62 (0.39–0.99)

0.62 (0.35–1.11)

1.02 (0.52–1.96)

Germ cell tumors [6]

1.15 (0.59–2.26)

1.23 (0.56–2.71)

1.62 (0.61–4.32)

Other epithelial neoplasms/melanomas [6]

1.82 (0.39–8.44)

0.44 (0.05–3.81)

1.06 (0.12–9.09)

Central nervous system [10]

0.96 (0.73–1.26)

0.90 (0.65–1.24)

1.20 (0.82–1.77)